Skip to main content

Day: May 19, 2021

Dialysis Market Size 2021 | Is Projected to Reach USD 177.56 by 2026, Exhibiting a CAGR of 7.7% During the Forecast Period

Top Players Covered in the dialysis market Research Report Are Fresius Care Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson, and Company, Diaverum Healthcare Partners, Medtronic, Asahi Kasei Corporation, Nipro Corporation and other key market players. Pune, India, May 19, 2021 (GLOBE NEWSWIRE) — The global dialysis market size is projected to reach USD 177.56 by 2026, exhibiting a CAGR of 7.7% during the forecast period. The market stood at USD 90.33 billion in 2019. The rising cases of chronic kidney disorders are expected to boost the visits to the hospital by patients for procuring renal therapy and foster the market growth, shares Fortune Business Insights™ in its report titled “Dialysis Market, 2020-2027.” Global Dialysis Market...

Continue reading

Midland Begins Major Exploration Program in Nunavik Under Its Strategic Alliance With SOQUEM

Figure 1Midland-SOQUEM Alliance Labrador TroughMONTREAL, May 19, 2021 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to report the start of a major exploration program for Cu-Zn-Co-Ag-Au / Zn-Pb-Cu-Ag-Au volcanogenic massive sulphides (VMS) in the Labrador Trough in Nunavik. This new program will be carried out under the Strategic Alliance (the “Alliance”) executed on February 19, 2021 between Midland and SOQUEM. The 2021 exploration program will consist of two helicopter-borne electromagnetic (“VTEM”) surveys as well as a prospecting program to be conducted in two phases, next June and August. Highlights:New exploration targets for Cu-Zn-Co-Ag-Au / Zn-Pb-Cu-Ag-Au VMS identified during recent compilation work Acquisition of 138 claims (63.6 km2) Helicopter-borne EM surveys (VTEM)...

Continue reading

Multiple Sclerosis Drugs Market Size 2021 | Is Projected to Reach USD 40.66 Billion by 2027, Exhibiting a CAGR of 7.1% during the Forecast Period

Top Players Covered in the Multiple Sclerosis Drugs Market Research Report are Bristol-Myers Squibb Company (New York, U.S.), Sanofi (Paris, France), Novartis AG (Basel, Switzerland), Pfizer Inc. (New York, U.S.), Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel), Merck & Co., Inc. (New Jersey, U.S.), F. Hoffmann-La Roche Ltd. (Basel, Switzerland), Biogen (Massachusetts, U.S.) and other key market players Pune, India, May 19, 2021 (GLOBE NEWSWIRE) — The global multiple sclerosis market size is set to gain momentum as several prominent pharmaceutical companies are participating in conducting clinical trials to discover innovative and efficient therapies for the treatment of this immune disorder. For example, in December 2019, Adamas Pharmaceuticals, Inc. announced the results of its phase 3 clinical trials on ADS-5102,...

Continue reading

Healthcare Analytics Market Size 2021 | Is Projected to Reach USD 80.21 Billion by 2026, Exhibiting a CAGR of 27.5%

Healthcare Analytics Market Key Players Studied in this Report Are Cerner Corporation, IBM Corporation (IBM Watson), Flatiron Health, Linguamatics, Allscripts Healthcare LLC, Epic Systems Corporation, Health Catalyst, Inovalon. Pune, India, May 19, 2021 (GLOBE NEWSWIRE) — According to the report, Healthcare Analytics market size is projected to reach USD 80.21 Billion value by 2026, exhibiting a CAGR of 27.5%. Launch of Cortellis Digital Health Intelligence Solution by Clarivate Analytics to Favor Healthcare Analytics Market. The market size stood at USD 11.59 billion in 2018. Healthcare analytics involves analyzing historical and current industrial data to effectively manage clinical data and patient’s diagnosis, forecast trends, and improve business. It is anticipated to revolutionize the functioning of healthcare organizations...

Continue reading

Decisions of Sampo plc’s Annual General Meeting

SAMPO PLC                 DECISIONS OF GENERAL MEETING    19 May 2021 at 2:15 pm Decisions of Sampo plc’s Annual General Meeting The Annual General Meeting of Sampo plc, held today on 19 May 2021, decided to distribute a dividend of EUR 1.70 per share for 2020. The record date for dividend payment is 21 May 2021 and the dividend will be paid on 28 May 2021. The Annual General Meeting adopted the financial accounts for 2020 and discharged the Board of Directors and the CEO from liability for the financial year. The Annual General Meeting elected eight members to the Board of Directors. The following members were re-elected to the Board: Christian Clausen, Fiona Clutterbuck, Georg Ehrnrooth, Jannica Fagerholm, Johanna Lamminen, Risto Murto and Björn Wahlroos. Markus Rauramo was elected as a new member to the Board. The Members of the Board...

Continue reading

Invesco ltd: Form 8.3 – Willis Tower Watson PLC – CORRECTION

                         Form 8.3 – CORRECTION IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MOREKEY INFORMATIONName of person dealing (Note 1) Invesco Ltd.Company dealt in Willis Towers Watson plcClass of relevant security to which the dealings being disclosed relate (Note 2) Ordinary Shares IE00BDB6Q211Date of dealing 18-05-2021INTERESTS AND SHORT POSITIONS(a)    Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)  Long Short  Number   (%) Number         (%)(1) Relevant securities 1,364,203          1.057%      2,900              0.002%(2) Derivatives (other than options)    (3) Options and agreements to purchase/sell    Total 1,364,203...

Continue reading

Reata Announces that The FDA Has Asked The Company to Request a Pre-NDA Meeting for Omaveloxolone for the Treatment of Friedreich’s Ataxia

PLANO, Texas, May 19, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that it received a communication from the Division of Neurology Products 1 (“Division”) of the U.S. Food and Drug Administration (“FDA”) stating that, after a preliminary review of briefing materials for an upcoming Type C meeting, a pre-NDA meeting is the most appropriate format for a discussion of the development program for omaveloxolone in Friedreich’s ataxia (“FA”). The Division suggested that the Company withdraw the current meeting request for a Type C meeting and instead request a pre-NDA meeting, which the Division will grant upon receipt. The Division asked the Company to focus the new briefing package on questions, issues, and needs applicable...

Continue reading

Lands’ End Announces First Quarter Fiscal 2021 Earnings Conference Call

DODGEVILLE, Wis., May 19, 2021 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Wednesday, June 2, 2021, to discuss its first quarter fiscal 2021 financial results. A news release containing these results will be issued before the call. Listeners may access a live broadcast of the conference call on the Company’s investor relations website: http://investors.landsend.com/ in the Events and Presentations section or by dialing (866) 753-5836. An online archive of the broadcast will be available at approximately noon on June 2, 2021, and will be accessible on the Company’s website: http://investors.landsend.com/ in the Events and Presentations section.   About Lands’ End, Inc. Lands’ End, Inc. (NASDAQ: LE) is a leading uni-channel retailer of casual clothing,...

Continue reading

Vista Gold Corp. Announces Drill Results for Step-out Drilling at the Mt Todd Gold Project, Including a 162 Grams of Gold per Tonne Intercept

Figure 1Plan View of Drill Holes and Cross Section LocationsFigure 2Section 8436400N View of VB21-004 and VB21-005 with VB21-002 Assay ResultsFigure 3Section 8436400N Enlarged View of VB21-005 and VB21-002 Drilling Assay ResultsFigure 4Section 8436400N Enlarged View of VB21-004 and Historic DrillingFigure 5Plan view of Surface Geochemistry, including Soil and Rock Chip Samples in the Vicinity of VB002 and VB21-005.DENVER, May 19, 2021 (GLOBE NEWSWIRE) — Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) today announced assay results for drilling at the Company’s Mt Todd gold project (“Mt Todd” or the “Project”). Two additional holes have been completed on an east-west section approximately 500 meters north of the limits of...

Continue reading

Sonoco ThermoSafe and Cathay Pacific Cargo Expand Partnership to Include Leasing of Pegasus ULD® Containers

ARLINGTON HEIGHTS, Ill., May 19, 2021 (GLOBE NEWSWIRE) — Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON) and the leading global provider of temperature assurance packaging, and Cathay Pacific Cargo, one of the world’s largest air cargo carriers, announced an expanded global partnership agreement for the leasing of the new Pegasus ULD® temperature controlled bulk shipping container. The agreement enables pharmaceutical freight forwarders to lease Pegasus ULD® containers directly from Cathay Pacific Cargo. Sonoco ThermoSafe’s Pegasus ULD® is the world’s first FAA and EASA-approved passive bulk temperature-controlled ULD container for pharmaceutical use, which enables it to speed through international air freight handling and customs processes at the lowest possible cost. With a focus on sustainability, the Pegasus is engineered with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.